Kimberly-Clark is buying Tylenol maker Kenvue in an approximately $48.7 billion cash-and-stock deal, creating a massive ...
Little more than a month after making specious claims that there’s a link between Tylenol use and autism, Health and Human ...
Potentially huge legal issues are hovering over Kenvue. But Kimberly-Clark, which agreed to buy it for $40 billion, appears ...
Many expectant moms are unaware of the dangers of cannabis use.
Not long after President Trump made his statement, Kenvue and Johnson & Johnson got into another complicated legal mess when ...
Kimberly-Clark Chairman and CEO Mike Hsu joins 'Mad Money' host Jim Cramer to talk the recent acquisition of Kenvue, ...